Skip to main content
Heidelberg Pharma AG (ETR:HPHA)
Germany flag Germany · Delayed Price · Currency is EUR
2.790
+0.090 (3.33%)
Apr 24, 2025, 5:36 PM CET

Heidelberg Pharma AG Revenue

In the fiscal year ending November 30, 2024, Heidelberg Pharma AG had annual revenue of 6.85M EUR, down -30.53%. Heidelberg Pharma AG had revenue of 1.60M in the quarter ending November 30, 2024, a decrease of -50.33%.

Revenue
6.85M
Revenue Growth
-30.53%
P/S Ratio
18.37
Revenue / Employee
65.23K
Employees
105
Market Cap
125.83M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Nov 30, 20246.85M-3.01M-30.53%
Nov 30, 20239.86M-8.66M-46.75%
Nov 30, 202218.51M16.48M810.30%
Nov 30, 20212.03M-6.63M-76.53%
Nov 30, 20208.67M1.17M15.63%
Nov 30, 2019 Pro Pro Pro
Nov 30, 2018 Pro Pro Pro
Nov 30, 2017 Pro Pro Pro
Nov 30, 2016 Pro Pro Pro
Nov 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.16B
Siemens Healthineers AG 22.67B
Fresenius SE & Co. KGaA 21.83B
Bayer Aktiengesellschaft 46.61B
Sartorius Aktiengesellschaft 3.44B
Fresenius Medical Care AG 19.34B
Carl Zeiss Meditec AG 2.08B
Fielmann Group AG 2.16B
Revenue Rankings

Heidelberg Pharma AG News

More News